PC 945

Drug Profile

PC 945

Alternative Names: PC945

Latest Information Update: 02 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pulmocide
  • Class Antifungals; Triazoles
  • Mechanism of Action 14-alpha demethylase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Aspergillosis

Most Recent Events

  • 23 Oct 2017 Phase-I clinical trials in Aspergillosis (In volunteers) in United Kingdom (Inhalation) (NCT02715570)
  • 26 Oct 2016 Interim pharmacodynamics data from a preclinical study in Aspergillosis released by Pulmocide
  • 30 Mar 2016 Preclinical trials in Aspergillosis in United Kingdom (Inhalation) before March 2016 (Pulmocide Pipeline, March 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top